---
title: "OrbusNeich Sets 2026 Board Line-Up and Committee Roles"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/273350127.md"
description: "OrbusNeich Medical Group Holdings Limited has announced its board composition effective January 22, 2026, which includes three executive directors, one non-executive director, and three independent non-executive directors. The company also updated its key board committees—Audit, Remuneration, and Nomination—clarifying the roles of directors. The latest analyst rating for OrbusNeich (HK:6929) is a Hold with a price target of HK$4.00. The company operates in the medical device sector, focusing on interventional cardiovascular solutions, with a current market cap of HK$3.19B."
datetime: "2026-01-22T09:08:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273350127.md)
  - [en](https://longbridge.com/en/news/273350127.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273350127.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/273350127.md) | [English](https://longbridge.com/en/news/273350127.md)


# OrbusNeich Sets 2026 Board Line-Up and Committee Roles

### Claim 50% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

The latest update is out from OrbusNeich Medical Group Holdings Limited ( (HK:6929) ).

OrbusNeich Medical Group Holdings Limited has announced the composition of its board of directors effective 22 January 2026, confirming three executive directors, one non-executive director and three independent non-executive directors. The company has also set out the updated membership of its three key board committees—Audit, Remuneration and Nomination—clarifying which directors serve as chairs and members, a move that formalizes its governance structure and reinforces board oversight for shareholders and other stakeholders.

The most recent analyst rating on (HK:6929) stock is a Hold with a HK$4.00 price target. To see the full list of analyst forecasts on OrbusNeich Medical Group Holdings Limited stock, see the HK:6929 Stock Forecast page.

**More about OrbusNeich Medical Group Holdings Limited**

OrbusNeich Medical Group Holdings Limited, incorporated in the Cayman Islands and listed in Hong Kong (Stock Code: 6929), operates in the medical device sector, focusing on interventional cardiovascular solutions and related technologies for global healthcare markets.

**Average Trading Volume:** 139,479

**Technical Sentiment Signal:** Sell

**Current Market Cap:** HK$3.19B

For an in-depth examination of 6929 stock, go to TipRanks’ Overview page.

### 相關股票

- [ORBUSNEICH (06929.HK)](https://longbridge.com/zh-HK/quote/06929.HK.md)

## 相關資訊與研究

- [OrbusNeich Medical Group posts FY profit attributable of $34.8 mln](https://longbridge.com/zh-HK/news/278865639.md)
- [Taizhou Water Group Signs New Connected Raw Water Supply Deal to 2028](https://longbridge.com/zh-HK/news/281542611.md)
- [AddLife Calls 2026 AGM With Incentive Plan and Share Issue Mandates on Agenda](https://longbridge.com/zh-HK/news/280991241.md)
- [US visa curbs fallout: Indian students in US drop 6.9% to 352,644 in 2026](https://longbridge.com/zh-HK/news/281606469.md)
- [Quantum Resistant Ledger (QRL) - QRL Show Live - 01 April 2026](https://longbridge.com/zh-HK/news/281304246.md)